Invenomic Capital Management LP Baxter International Inc Transaction History

Invenomic Capital Management LP

  • $1.75 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$31.71 - $38.95 $12.9 Million - $15.8 Million
-406,535 Reduced 76.05%
128,001 $4.95 Million
Q3 2023

Nov 14, 2023
BUY
$37.32 - $49.29 $507,141 - $669,801
13,589 Added 2.61%
534,536 $20.2 Million
Q2 2023

Aug 14, 2023
SELL
$39.98 - $47.68 $1.65 Million - $1.96 Million
-41,193 Reduced 7.33%
520,947 $23.7 Million
Q1 2023

May 15, 2023
BUY
$37.58 - $52.57 $21.1 Million - $29.6 Million
562,140 New
562,140 $22.8 Million

Others Institutions Holding BAX

# of Institutions
1,008
Shares Held
451M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email